Arno Therapeutics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.

Cash Flow

Arno Therapeutics, Inc. (OTC:ARNI): Cash Flow
2012 -9.41M 0 13.68M
2013 -14.24M 0 30.07M
2014 -18.80M -20.35K 0
2015 -9.96M 0 2.08M
2019 0 0 0
2020 0 0 0
2021 0 0 0
2022 0 0 0

ARNI Cash Flow Statement (2012 – 2022)

2022 2021 2020 2019 2015 2014 2013 2012
Cash at beginning of period
 00007.94M26.77M10.94M6.67M
Operating activities
Net income
 0000-11.50M7.77M-39.65M-14.38M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
 00007.62K12.58K13.11K13.83K
Stock-based compensation expense
 00003.47M4.52M1.45M722.81K
Deferred income tax benefit 00003.47M4.52M1.45M722.81K
Changes in operating assets and liabilities:
Accounts receivable, net
 00000000
Inventories
 00000000
Accounts payable
 0000267.76K-2.19M1.38M869.99K
Cash generated by operating activities
 0000-9.96M-18.80M-14.24M-9.41M
Investing activities
Purchases Of Investments
 00000000
Investments In Property Plant And Equipment
 00000-20.09K00
Acquisitions Net
 00000000
Cash generated by investing activities
 00000-20.35K00
Financing activities
Common Stock Issued
 00000000
Payments for dividends
 00000000
Repurchases of common stock
 00000000
Repayments of term debt
 00002.09M000
Cash used in financing activities
 00002.08M030.07M13.68M
Net Change In Cash
 0000-7.88M-18.82M15.83M4.26M
Cash at end of period
 000066.98K7.94M26.77M10.94M